Sensus Healthcare
SRTS
21 hedge funds and large institutions have $3.5M invested in Sensus Healthcare in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
5% more funds holding
Funds holding: 20 → 21 (+1)
2.83% less ownership
Funds ownership: 9.73% → 6.9% (-2.8%)
13% less capital invested
Capital invested by funds: $4.01M → $3.5M (-$514K)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
+$133K |
| 2 |
SBIA
Sheaff Brock Investment Advisors
Indianapolis,
Indiana
|
+$30K |
| 3 |
Renaissance Technologies
New York
|
+$29.3K |
| 4 |
BlackRock
New York
|
+$13.3K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$185 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$663K |
| 2 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
-$85.9K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$12.9K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$6.54K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$5K |
SRTS Hedge Fund Activity: Q2 2020 in Review
21 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Sensus Healthcare (SRTS) for Q2 2020, worth a combined $3.5M — down 13% from $4.01M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new SRTS positions and 2 closed out — a net gain of 2 holders — while 2 added to existing stakes and 3 trimmed.
The largest buyer was Invenomic Capital Management, adding an estimated $133K. The largest seller was Heartland Advisors, exiting entirely with an estimated $663K sold.
- 21 institutional investors held Sensus Healthcare (SRTS) as of Q2 2020, up from 20 in Q1 2020.
- Funds reported $3.5M of Sensus Healthcare stock for Q2 2020, down 13% quarter-over-quarter.
- 4 funds opened new Sensus Healthcare positions in Q2 2020 and 2 closed out, a net change of +2 holders.
- The largest Sensus Healthcare buyer in Q2 2020 was Invenomic Capital Management, an estimated $133K added.
- The largest Sensus Healthcare seller in Q2 2020 was Heartland Advisors, an estimated $663K sold.
Based on aggregated 13F filings for Q2 2020.